| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45963-480-03 | 45963-480 | HUMAN PRESCRIPTION DRUG | Alosetron Hydrochloride | alosetron hydrochloride | TABLET | ORAL | 20150526 | 20260430 | NDA AUTHORIZED GENERIC | NDA021107 | Actavis Pharma, Inc. | ALOSETRON HYDROCHLORIDE | 1 mg/1 | 1 BOTTLE in 1 CARTON (45963-480-03) / 30 TABLET in 1 BOTTLE |
| 45963-479-03 | 45963-479 | HUMAN PRESCRIPTION DRUG | Alosetron Hydrochloride | alosetron hydrochloride | TABLET | ORAL | 20150526 | 20260430 | NDA AUTHORIZED GENERIC | NDA021107 | Actavis Pharma, Inc. | ALOSETRON HYDROCHLORIDE | .5 mg/1 | 1 BOTTLE in 1 CARTON (45963-479-03) / 30 TABLET in 1 BOTTLE |
| 54766-895-03 | 54766-895 | HUMAN PRESCRIPTION DRUG | LOTRONEX | alosetron hydrochloride | TABLET | ORAL | 20160711 | 20260430 | NDA | NDA021107 | Sebela Pharmaceuticals Inc. | ALOSETRON HYDROCHLORIDE | 1 mg/1 | 30 TABLET in 1 BOTTLE (54766-895-03) |
| 54766-894-03 | 54766-894 | HUMAN PRESCRIPTION DRUG | LOTRONEX | alosetron hydrochloride | TABLET | ORAL | 20160711 | 20260430 | NDA | NDA021107 | Sebela Pharmaceuticals Inc. | ALOSETRON HYDROCHLORIDE | .5 mg/1 | 30 TABLET in 1 BOTTLE (54766-894-03) |